483
Ulhas M. Nadgir, M.D.FDA 483 - Ulhas M. Nadgir, M.D. - October 10, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Ulhas M. Nadgir, M.D., Clinical Investigator in Sacramento, CA, from October 7-10, 2024, revealed a significant deviation from the investigational plan. The primary concern was the enrollment and treatment of a study subject who met an exclusion criterion, indicating a failure to conduct the investigation in accordance with the signed statement of investigator.
Open in Dashboard
ID · debfed98-2dbc-4e2d-9b64-68e27716e151